Stephen V. Faraone, MD, PhD

home / authors / stephen-v-faraone-md-phd

Articles

Novel Drug Delivery Systems in ADHD and Take-Home Messages

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 28th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.

Implications of Pharmacogenetic Testing in ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 28th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss implications of pharmacogenetic testing in ADHD.

Case 3: Factors Driving Treatment Selection in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 21st 2022

ADHD experts discuss factors that drive treatment selection when selecting therapy for an adult with ADHD.

Case 3: Treatment Goals in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 21st 2022

Theresa Cerulli, MD, and Andrew J. Cutler, MD, provide insight on goals of therapy for patients with ADHD.

Case 3: 24-Year-Old Patient With ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 21st 2022

Stephen Faraone, PhD, presents the case of a 24-year-old patient with ADHD.

Patient Case #2: Importance of an Integrative Approach in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 14th 2022

ADHD experts discuss the importance of an integrative approach in the treatment of adults with ADHD.

Patient Case #2: Addressing Non-Adherence and Stigma of Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 14th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss addressing non-adherence and the stigma of ADHD.

Patient Case #2: Dealing With Comorbidities in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 7th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.

Patient Case #2: Impressions and Challenges in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 7th 2022

Experts in psychiatry provide insight on a patient case as well as discuss challenges with ADHD.

Patient Case #2: A 23-Year-Old Patient With ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

October 7th 2022

Stephen Faraone, PhD, presents the case of a 23-year-old patient with ADHD.

Patient Case #1: Dealing With Treatment Delay in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 30th 2022

A panel of ADHD specialists discuss the impact of treatment delay when dealing with an adult patient.

Patient Case #1: Co-Managing ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 30th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to co-manage a patient with ADHD with other specialties.

Patient Case #1: Differentiating Between ADHD and Other Psychiatric Comorbidities

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 23rd 2022

Experts in psychiatry discuss tips to differentiate between ADHD and other co-morbid psychiatric disorders.

Patient Case #1: Prompting an ADHD Consultation

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 23rd 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss factors which prompt adults for an ADHD consultation.

Patient Case #1: 19-Year-Old Male With ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 23rd 2022

Stephen Faraone, PhD, presents the case of a 19-year-old male with ADHD.

Future of Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 16th 2022

Experts in psychiatry discuss the future of ADHD management as well as challenges when approaching treatment of adult ADHD.

Efficacy and Safety of Treatment Options Utilized in Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 16th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss efficacy and safety of treatment options in adults with ADHD.

Unmet Needs in the Treatment of Adult ADHD

Stephen V. Faraone, MD, PhD;Theresa Cerulli, MD;Craig Chepke, MD, DFAPA, FAPA;Andrew J. Cutler, MD

September 16th 2022

Craig Chepke, MD, FAPA, and Andrew J. Cutler, MD, discuss unmet needs in adults with ADHD.

Upcoming Podcast on ADHD Treatment Options

Stephen V. Faraone, MD, PhD;Chris Aiken, MD

December 23rd 2021

Crime and Therapy: Good News About Pharmacotherapy for ADHD

Stephen V. Faraone, MD, PhD

July 16th 2013

Some criminal activity can be eliminated by pharmacotherapy for ADHD. Should this information influence clinical practice? The short answer is an unequivocal “yes.”

The Molecular Genetics of ADHD: A View From the IMAGE Project

Stephen V. Faraone, MD, PhD;Philip Asherson, MRCPsych, PhD

August 1st 2005

New research into the genetic basis and possible genetic markers for attention-deficit/hyperactivity disorder may open the door for new treatments. There is a clear concordance between twins who have ADHD, as well as siblings. What can genetic mapping tell us about treating ADHD?

Clinical Uses and Ethical Implications of Psychiatric Genetic Counseling

Debby W. Tsuang, MD;Stephen V. Faraone, MD, PhD;Ming T. Tsuang, MD, PhD, DSc

October 1st 2001

The Human Genome project has provided an abundance of genetic information, including identification of many disease-causing genes. Clinical applications, genetic counseling and the potential ethical issues raised by the availability of genetic testing are all areas of concern in gene research. Will genetic counseling in classical genetic diseases help to provide guidelines for behavioral disorders?